Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice Variations in the Management of <i>Clostridioides difficile</i> Infection: Findings From a Survey of US Physicians.

Gastro hep advances·2026
Same author

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Decomposable and Essentially Univariate Mass-Action Systems: Extensions of the Deficiency One Theorem.

Journal of nonlinear science·2026
Same author

Palbociclib in Patients With HR+/HER2- Advanced or Metastatic Breast Cancer and Bone-Only Metastasis: A Systematic Literature Review.

Clinical breast cancer·2026
Same author

Phosphate binders and the gut microbiota in chronic kidney disease: mechanisms, mixed evidence, and clinical considerations.

Journal of nephrology·2026
Same author

Repeat multiplex PCR gastrointestinal panel testing within 14 days yields minimal additional diagnostic information: a multicenter cohort study.

Infection control and hospital epidemiology·2026

Related Experiment Video

Updated: Jun 8, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay?

Abhishek Deshpande1, Vinay Pasupuleti, Chaitanya Pant

  • 1School of Biomedical Sciences, Kent State University, Kent, Ohio, USA. deshpaa@ccf.org

Current Medical Research and Opinion
|October 7, 2010
PubMed
Summary

Repeat stool testing for Clostridium difficile (C. difficile) toxin using enzyme immunoassay (EIA) is not recommended due to weak evidence. Newer algorithms offer increased sensitivity for diagnosing C. difficile infection.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

Related Experiment Videos

Last Updated: Jun 8, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Diagnostic testing

Background:

  • Clostridium difficile infection (CDI) diagnosis relies on accurate toxin detection.
  • Enzyme immunoassays (EIA) for C. difficile toxins A&B have limitations in sensitivity.
  • Current guidelines suggest multi-step algorithms for CDI diagnosis.

Purpose of the Study:

  • To review the literature on the utility of repeat stool testing for C. difficile toxin using EIA.
  • To propose an updated diagnostic algorithm for C. difficile.

Main Methods:

  • Comprehensive literature search of PubMed, Web of Science, and Scopus databases.
  • Inclusion of articles discussing EIA for C. difficile toxin detection.
  • Evaluation of relevant cross-references for study inclusion.

Main Results:

  • Evidence supporting repeat stool testing for C. difficile toxin EIA is diminishing.
  • Current practice guidelines advocate for two- or three-step diagnostic algorithms.
  • EIA alone demonstrates limited sensitivity for C. difficile toxin detection.

Conclusions:

  • Repeat stool testing for C. difficile toxin via EIA is not clinically warranted.
  • Multi-step diagnostic approaches significantly enhance sensitivity for CDI.
  • Further research is needed for definitive guidelines on optimal CDI diagnostic workup.